Eculizumab treatment of paroxysmal nocturnal hemoglobinuria presenting as moyamoya syndrome in a 9-year-old male. | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Eculizumab treatment of paroxysmal nocturnal hemoglobinuria presenting as moyamoya syndrome in a 9-year-old male.

Eculizumab treatment of paroxysmal nocturnal hemoglobinuria presenting as moyamoya syndrome in a 9-year-old male.

Journal Title: 
Pediatr Blood Cancer
Primary Author: 
Yen TA, Lu MY, Kuo MF, Huang CC, Chen JS, Yang YL
Author(s): 
Yen TA
Original Publication Date: 
Monday, January 9, 2012
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/22231749/

No abstract available

Bone Marrow Disease(s): 
  • paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.